2023
DOI: 10.5603/pjnns.a2023.0004
|View full text |Cite
|
Sign up to set email alerts
|

Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians

Abstract: The purpose of this literature review was to summarise relevant findings regarding the clinical management of multiple sclerosis (MS) in the COVID-19 pandemic, with the focus on patient risks, and the implications of disease-modifying treatment, both on COVID-19 severity and on the response to the SARS-CoV-2 vaccinations. Although MS per se does not seem to put patients at risk for more severe COVID-19, alongside the risk factors known to apply to the general population, progressive disease course, higher disa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 80 publications
0
1
0
Order By: Relevance
“…In this issue, we also present two articles concerning the impact of SARS-CoV-2 infection on the course of multiple sclerosis [44] and other autoimmune diseases of the nervous system [45]. The introduction of vaccination against SARS--CoV-2 was another challenge in this group of patients.…”
mentioning
confidence: 99%
“…In this issue, we also present two articles concerning the impact of SARS-CoV-2 infection on the course of multiple sclerosis [44] and other autoimmune diseases of the nervous system [45]. The introduction of vaccination against SARS--CoV-2 was another challenge in this group of patients.…”
mentioning
confidence: 99%